This article has been updated with additional comment from the FDA.
NEW YORK – The US Food and Drug Administration on Saturday said that it will work with the National Cancer Institute and the National Institute of Allergy and Infectious Diseases to establish the validity of serological tests for determining whether individuals have antibodies to SARS-CoV-2.